Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 05 - 13    source : Www.biospace.com    save search

LivaNova to Present at the UBS Global Healthcare Virtual Conference
Published: 2021-05-13 (Crawled : 22:00) - biospace.com/
LIVN | $52.31 -0.85% -0.86% 430K twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 2.02% C: 1.04%

conference presentation
Regulus Therapeutics Reports First Quarter 2021 Financial Results and Recent Updates
Published: 2021-05-13 (Crawled : 22:00) - biospace.com/
RGLS | $2.13 -4.05% -4.23% 220K twitter stocktwits trandingview |
Health Technology
| | O: -3.43% H: 6.77% C: -1.2%

financial results results
Marinus Pharmaceuticals Reschedules First Quarter 2021 Financial Results Conference Call
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
MRNS | $1.38 -2.13% -2.17% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.88% H: 5.86% C: 2.76%

financial results results conference
DermTech Reports First Quarter 2021 Financial Results
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
DMTK 4 | $0.6423 8.68% 7.99% 660K twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 5.28% C: -6.18%

financial results results report
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
PHAS | $0.0701 -23.97% twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 5.52% C: -3.45%

financial results results
Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
PLSE | $7.2 -2.17% -2.22% 180K twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 3.13% C: -9.93%

laser results technology conference
Aptinyx Reports First Quarter 2021 Financial Results and Highlights
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
APTX | $0.061 21.31% 7.8M twitter stocktwits trandingview |
Health Services
| | O: 0.41% H: 0.0% C: -3.24%

financial results results
Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2021 Financial Results
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
ALPN | $64.535 0.16% 0.16% 4M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 2.16% C: -0.86%

financial results results
AbCellera Reports Q1 2021 Business Results
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K twitter stocktwits trandingview |
| | O: -3.42% H: 17.96% C: 15.07%

results report
TYME Appoints Frank L. Porfido as Chief Financial Officer
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
TYME | $0.3107 -8.21% twitter stocktwits trandingview |
Health Technology
| | O: 3.42% H: 3.31% C: -5.79%


Headlands Research Continues its Rapid Expansion with the Acquisition of Summit Research Network and the Launch of its Fourth Horizons Site
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
KKR | $92.62 -0.78% 0.0% 4.5M twitter stocktwits trandingview |
Finance
| | O: 0.46% H: 1.78% C: 1.42%

acquisition expansion research
Horizon Therapeutics plc Ranked #1 in Overall Corporate Reputation Among U.S. Patient Groups that Report Working with the Company
Published: 2021-05-13 (Crawled : 21:00) - biospace.com/
HZNP | $116.3 0.03% 29M twitter stocktwits trandingview |
Health Technology
| | O: 0.47% H: 1.94% C: 0.89%

xin
FSD Pharma Announces Filing of Criminal Complaint Against Former Chief Financial Officer
Published: 2021-05-13 (Crawled : 20:00) - biospace.com/
HUGE | $0.6167 1.22% 29K twitter stocktwits trandingview |
Process Industries
| | O: 4.24% H: 0.0% C: -5.81%

pharma
Emergent Bio Execs to Testify Before Congress Following Vaccine Manufacturing Mistake
Published: 2021-05-13 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 2.23% C: 1.79%

test vaccine merge
Emergent Bio Execs to Testify Before Congress Following Vaccine Manufacturing...
Published: 2021-05-13 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 2.23% C: 1.79%

test vaccine merge
Lilly to Participate in UBS Global Healthcare Virtual Conference
Published: 2021-05-13 (Crawled : 16:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 2.01% C: 1.4%

conference
Medtronic to Announce Financial Results for its Fourth Quarter and Full Fiscal Year 2021
Published: 2021-05-13 (Crawled : 15:15) - biospace.com/
MDT | $79.48 0.37% -0.29% 6.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 1.3% C: 0.66%

financial results results
The Latest News in the Battle Against COVID-19
Published: 2021-05-13 (Crawled : 15:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 2.23% C: 1.79%
BNTX | $86.82 0.75% 0.75% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.18% H: 0.86% C: -4.0%

covid test covid-19
Daré Bioscience Reports First Quarter 2021 Financial Results and Provides a Company UpdateConference Call and Webcast Today at 4:30 p.m. Eastern Time
Published: 2021-05-13 (Crawled : 13:15) - biospace.com/
DARE | $0.2838 -3.83% -3.98% 550K twitter stocktwits trandingview |
Health Technology
| | O: 3.15% H: 2.29% C: -5.34%

financial results results oda conference
Merus Announces Collaborations in Israel, Italy and Spain to Increase Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the Phase 1/2 eNRGy Clinical Trial
Published: 2021-05-13 (Crawled : 13:15) - biospace.com/
MRUS | $39.83 -1.58% -1.61% 800K twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 2.72% C: -1.83%

israel phase 1 collaboration cancer announces collaboration trial phase 3 phase 2
Gainers vs Losers
67% 33%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.